The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
Site Search
Showing 51 - 52 of 52 results
News
|
March 2, 2012
|
1 min read
News
|
Aug. 31, 2012
|
1 min read